Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B

被引：0
作者：
Benoit Guillet
Songkai Yan
Becky Hooper
Douglass Drelich
Jason Steenkamp
Radovan Tomic
Maria Elisa Mancuso
机构：
[1] Hemophilia Treatment Center of Rennes-Bretagne,
[2] University Hospital Center (CHU) Rennes,undefined
[3] CSL Behring,undefined
[4] EVERSANA,undefined
[5] CSL Behring,undefined
[6] IRCCS Humanitas Research Hospital and Humanitas University,undefined
来源：
Advances in Therapy | 2024年 / 41卷
关键词：
Efficacy; Hemophilia B; Matching-adjusted indirect comparisons; Prophylactic treatment; Recombinant factor IX albumin fusion protein; Recombinant factor IX Fc fusion protein;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：649 / 658
页数：9
相关论文
共 50 条
[31]   Conformational Comparability of Factor IX-Fc Fusion Protein, Factor IX, and Purified Fc Fragment in the Absence and Presence of Calcium [J].
Houde, Damian ;
Berkowitz, Steven A. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (05) :1688-1700
[32]   BAX326 (recombinant coagulation factor IX) for the treatment and prophylaxis of hemophilia B [J].
Windyga, Jerzy ;
Abbuehl, Brigitt E. ;
Hafeman, Andrea E. .
EXPERT REVIEW OF HEMATOLOGY, 2014, 7 (03) :333-342
[33]   Population Pharmacokinetics of Recombinant Factor VIII Fc Fusion Protein [J].
Nestorov, Ivan ;
Neelakantan, Srividya ;
Ludden, Thomas M. ;
Li, Shuanglian ;
Jiang, Haiyan ;
Rogge, Mark .
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2015, 4 (03) :163-174
[34]   Real-World Use of Albutrepenonacog Alfa, A Recombinant Coagulation Factor IX Albumin Fusion Protein, for Personalized Prophylaxis in Japanese Individuals With Hemophilia B: A Case Series [J].
Nagao, Azusa ;
Bingo, Masato ;
Yamaguchi, Tomoko ;
Fukutake, Katsuyuki .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[35]   Systematic review and analysis of efficacy of recombinant factor IX products for prophylactic treatment of hemophilia B in comparison with rIX-FP [J].
Davis, Joanna ;
Yan, Songkai ;
Matsushita, Tadashi ;
Alberio, Lorenzo ;
Bassett, Paul ;
Santagostino, Elena .
JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (10) :1014-1021
[36]   Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors [J].
Pochopien, Michal ;
Tytula, Anna ;
Toumi, Mondher ;
Falk, Aletta ;
Martone, Nicoletta ;
Hakimi, Zalmai ;
Eriksson, Daniel .
ADVANCES IN THERAPY, 2024, 41 (06) :2307-2323
[37]   Comparative field study: impact of laboratory assay variability on the assessment of recombinant factor IX Fc fusion protein (rFIXFc) activity [J].
Sommer, Jurg M. ;
Yang Buyue ;
Bardan, Sara ;
Peters, Robert T. ;
Jiang, Haiyan ;
Kamphaus, George D. ;
Gray, Elaine ;
Pierce, Glenn F. .
THROMBOSIS AND HAEMOSTASIS, 2014, 112 (05) :932-940
[38]   Recombinant factorVIII Fc fusion protein for the prevention and treatment of bleeding in children with severe hemophilia A [J].
Young, G. ;
Mahlangu, J. ;
Kulkarni, R. ;
Nolan, B. ;
Liesner, R. ;
Pasi, J. ;
Barnes, C. ;
Neelakantan, S. ;
Gambino, G. ;
Cristiano, L. M. ;
Pierce, G. F. ;
Allen, G. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (06) :967-977
[39]   Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples [J].
Sommer, Jurg M. ;
Sadeghi-Khomami, Ali ;
Barnowski, Christopher ;
Wiken, Margareta ;
Willemze, Annemieke J. .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (03) :350-358
[40]   Long-acting recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in children Results of a phase 3 trial [J].
Kenet, Gili ;
Chambost, Herve ;
Male, Christoph ;
Lambert, Thierry ;
Halimeh, Susan ;
Chernova, Tatiana ;
Mancuso, Maria Elisa ;
Curtin, Julie ;
Voigt, Christine ;
Li, Yanyan ;
Jacobs, Iris ;
Santagostino, Elena .
THROMBOSIS AND HAEMOSTASIS, 2016, 116 (04) :659-668
12345